Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    FMAU
Show Display Options
Rank Status Study
1 Suspended 18F-FMAU PET/CT in Imaging Patients With Advanced Cancers
Condition: Malignant Neoplasm
Interventions: Radiation: fluorine F 18 d-FMAU;   Procedure: positron emission tomography;   Procedure: computed tomography
2 Recruiting 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer
Condition: Prostate Neoplasm
Interventions: Device: CAT;   Radiation: Fluorine F 18 d-FMAU;   Other: Laboratory Biomarker Analysis;   Procedure: Multiparametric Magnetic Resonance Imaging;   Device: Positron Emission Tomography;   Device: Ultrasound
3 Terminated Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
Condition: Hepatitis B
Intervention: Drug: Clevudine
4 Terminated Safety and Antiviral Activity Study of Clevudine 30 Mg QD in Patients With HBeAg(-) Chronic HBV
Condition: Hepatitis B
Intervention: Drug: Clevudine
5 Terminated Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
Condition: Hepatitis B
Intervention: Drug: Clevudine
6 Terminated Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
Condition: Hepatitis B
Intervention: Drug: Clevudine
7 Unknown  A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
Condition: Hepatitis B
Intervention: Drug: clevudine (drug)
8 Terminated Safety and Antiviral Activity Study of Clevudine 30 Mg QD in Patient With Chronic HBV
Condition: Hepatitis B
Intervention: Drug: clevudine
9 Completed Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Intervention: Drug: Clevudine
10 Terminated ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy
Conditions: HBe Negative Chronic Hepatitis B;   Hepatitis B Viral Infection
Interventions: Drug: CLEVUDINE + TENOFOVIR PLACEBO;   Drug: CLEVUDINE IN ASSOCIATION TENOFOVIR;   Drug: TENOFOVIR + CLEVUDINE PLACEBO
11 Completed A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B
Condition: Patients With LC-B
Interventions: Drug: Clevudine;   Drug: Adefovir dipivoxil
12 Completed Long-term Study With Clevudine
Condition: Chronic Hepatitis B
Intervention: Drug: Clevudine
13 Terminated Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B Virus
Condition: Hepatitis B
Intervention: Drug: clevudine
14 Terminated A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period
Condition: Chronic Hepatitis B
Intervention: Drug: Clevudine
15 Completed An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Clevudine 30mg;   Drug: Clevudine 20mg+Adefovir dipivoxil 10mg;   Drug: Clevudine 20mg
16 Completed A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)
Condition: HBeAg(+) Chronic Hepatitis B
Interventions: Drug: Clevudine;   Drug: Clevudine + Peg-interferon
17 Completed Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBV
Condition: Hepatitis B
Interventions: Drug: Clevudine;   Biological: Purified hepatitis B surface antigen
18 Terminated A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Clevudine, Adefovir
19 Completed A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCC
Condition: Hepatitis B Associated Hepatocellular Carcinoma
Intervention: Drug: clevudine, Adefovir
20 Completed Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
Condition: Hepatitis B
Intervention: Drug: Clevudine

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.